Cytology history preceding cervical cancer diagnosis: A regional analysis of 286 cases

Background:Despite programmed screening in the Netherlands, the decrease in incidence of cervical carcinoma lags behind. We analysed screening results preceding carcinoma cases, timeliness in case of follow-up, and FIGO (International Federation of Gynaecology and Obstetrics) stages as efficiency parameters for screening were taken.Methods:We analysed 286 women with cervical cancer between 2005 and 2007 for cytology history preceding carcinoma, hierarchically arranging cytology history (if present) into three groups: screened, work-up, and underscreened (6 yrs before diagnosis). For screen-and work-up smears, we analysed timeliness. FIGO stage was measured in relation to cytology history.Results:A total of 105 out of 286 (36.7%) women with cervical carcinoma were screened preceding the diagnosis. Delayed time intervals in case of abnormal cytology were 43.5% for borderline/mild dyskaryosis (BMD) and 38.0% for BMD (moderate dyskaryosis or worse; P0.51). A total of 108 out of 286 (36.4%) women were underscreened, and 73 out of 286 (25.5%) were unscreened. Advanced carcinoma or FIGO stage 2B in screened women was 16.0 vs 48.7% in work-up, underscreened, or unscreened (P0.001).Conclusion:Women with cervical cancer are underscreened and have poor timeliness in case of abnormal cytology. Being un-or underscreened correlates significantly with higher cervical cancer stages, especially in older women (aged 49 years; P0.001). Improvement of attendancy is needed to meet the standard of quality for screening programmes.